MCRB(MCRB)
MCRB
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $14M | $273,500 | $273,500 | $547,000 | $547,000 |
| Low | $2M | $42,302 | $42,302 | $84,605 | $84,605 |
| High | $25M | $504,697 | $504,697 | $1M | $1M |
| EBITDA Avg | $-30M | $-72M | $-37M | $-70M | $-79M |
| Low | $-58M | $-85M | $-62M | $-155M | $-173M |
| High | $11M | $12M | $-13M | $14M | $15M |
| EBIT Avg | $-33M | $-75M | $-40M | $-72M | $-81M |
| Low | $-61M | $-88M | $-65M | $-156M | $-175M |
| High | $8M | $9M | $-15M | $13M | $14M |
| Net Income Avg | $-37M | $-79M | $-44M | $-77M | $-85M |
| Low | $-65M | $-92M | $-69M | $-161M | $-179M |
| High | $3M | $4M | $-19M | $8M | $8M |
| EPS Avg | $-3.52 | $-4.95 | $-4.97 | $-8.64 | $-9.61 |
| Low | $-7.38 | $-10.38 | $-7.78 | $-18.13 | $-20.17 |
| High | $0.35 | $0.49 | $-2.17 | $0.85 | $0.95 |
| Analysts (Rev / EPS) | 1 / 1 | 2 / 1 | 2 / 2 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $6M | $6M |
| Low | $300,154 | $300,391 |
| High | $12M | $12M |
| EBITDA Avg | $-8M | $-8M |
| Low | $-20M | $-20M |
| High | $4M | $4M |
| EBIT Avg | $-10M | $-10M |
| Low | $-22M | $-22M |
| High | $3M | $3M |
| Net Income Avg | $-10M | $-10M |
| Low | $-22M | $-22M |
| High | $2M | $2M |
| EPS Avg | $-1.00 | $-1.01 |
| Low | $-2.25 | $-2.27 |
| High | $0.24 | $0.24 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |